A detailed history of Smith Thornton Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Smith Thornton Advisors LLC holds 3,813 shares of JNJ stock, worth $592,540. This represents 0.41% of its overall portfolio holdings.

Number of Shares
3,813
Previous 3,572 6.75%
Holding current value
$592,540
Previous $522 Million 18.33%
% of portfolio
0.41%
Previous 0.38%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$145.48 - $167.38 $35,060 - $40,338
241 Added 6.75%
3,813 $618 Million
Q2 2024

Aug 15, 2024

BUY
$144.38 - $157.78 $515,725 - $563,590
3,572 New
3,572 $522 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Smith Thornton Advisors LLC Portfolio

Follow Smith Thornton Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Thornton Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smith Thornton Advisors LLC with notifications on news.